Its expression was subsequently confirmed in human BM-MSCs [15], and in fact, our group showed that CD39 is expressed in MSCs from the normal cervix and cervical cancer [44], while others have shown its presence in limbal and dermal tissue [59] and pharynx and larynx and head and neck cancer [60]. This evidence concerns the gene ENTPD1 and head and neck cancer.